Dr. Chen’s research areas include:
- Using the comprehensive genomic technologies to discover new genetic abnormalities in acute lymphocytic leukemia that may serve as diagnostic and therapeutic targets.
- Co-PI member in a multidisciplinary team of clinicians and scientists who are on several different NCI and LLS Grants, the research focus of those grant is on translating molecular discoveries and prognostic genes and signatures to the clinical setting where they are been used to improve diagnosis, risk classification and therapeutic targeting
ISSUED U.S. PATENTS (UNM-AFFILIATED)
8,568,974 Discovery of Novel Biologic Groups and New Diagnostic and Therapeutic Targets in High Risk B Precursor Acute Lymphblastic Leukemia Through Gene Expression Profiling, issued October 29, 2013
PENDING U.S. PATENT APPLICATIONS (UNM-AFFILIATED)
Identification of Ph-like Acute Lymphoblastic Leukemia in Children and Adults Using a Gene Expression Predictor